🔎 Trials Near Me

Beranda › Degenerasi Makula › Indiana

Uji klinis Degenerasi Makula di Indiana

7 studi untuk Degenerasi Makula mencari peserta di lokasi di Indiana.

Kota di Indiana

Teks studi resmi (Bahasa Inggris)

A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)

  • Associated Vitreoretinal and Uveitis Consultants, Carmel
  • Midwest Eye Institute, Carmel
Menerima pesertaFase 2/3
Usia 50 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT07440225

A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

  • Midwest Eye Institute, Carmel
Menerima pesertaFase 2/3
Usia 60 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT06635148

Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD

  • Retina Partners Midwest, P.C., Carmel
Menerima pesertaFase 2
Usia 55 ke atas · Semua jenis kelamin · Diperbarui 10 Sep 2026 · NCT06659445

4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration

  • Retina Partners Midwest, Carmel
Menerima pesertaFase 1/2
Usia 50 ke atas · Semua jenis kelamin · Diperbarui 21 Agu 2026 · NCT05197270

Study to Assess the Adverse Events and How Intravitreal ABBV-6628 Moves Through the Body of Adult Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

  • Retina Partners Midwest, P.C. /ID# 262172, Carmel
Menerima pesertaFase 1/2
Usia 50 ke atas · Semua jenis kelamin · Diperbarui 13 Jul 2026 · NCT07160179

Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration

  • Retina Partners Midwest, PC, Carmel
Menerima pesertaFase 3
Usia 50 ke atas · Semua jenis kelamin · Diperbarui 16 Apr 2026 · NCT07064759

Study to Evaluate the Safety of CG-P5 Peptide Eye Drops in Patients Diagnosed With Age-related Wet Macular Degeneration

  • CBCC Global Research Site:004, Carmel
Menerima pesertaFase 1
Usia 50 ke atas · Semua jenis kelamin · Diperbarui 7 Feb 2025 · NCT06132035

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.